Date: 2012-08-20
Type of information: R&D agreement
Compound: novel medical products
Company: Alligator Bioscience (Sweden) undisclosed Swedish biotech company
Therapeutic area: undisclosed
Type agreement: R&D
Action mechanism:
Disease: undisclosed
Details: Alligator Bioscience has announced a research agreement with a Swedish biotech company to develop novel medical products. Under the terms of the agreement, Alligator Bioscience will apply it’s proprietary protein optimization technology FIND® (Fragment INduced Diversity) to generate novel medical products within the consumer health care sector.
Financial terms: Alligator Bioscience will receive upfront and research payments as well as development milestones and royalties on commercialized products.
Latest news:
